Variable Endokrinoloji / Hipofiz

Craniopharyngioma and Parasellar Masses — Differential Diagnosis, Hypothalamic Involvement, and Water Loss with Impaired Thirst

Masses originating from the region ABOVE the pituitary gland are a DISTINCT DISEASE GROUP from the pituitary's own tumors because they affect not only hormone production but also the HYPOTHALAMUS region directly above it. This region regulates THIRST, SATIETY, BODY TEMPERATURE, and SLEEP PATTERNS; therefore, in these patients, in addition to hormone deficiency, UNCONTROLLED WEIGHT GAIN, SLEEP DISTURBANCES, BEHAVIOR CHANGES, and TEMPERATURE DYSREGULATION are observed.

THE MOST DANGEROUS CONDITION IS THE LOSS OF THIRST: the patient has both WATER LOSS DISEASE and the THIRST SENSATION has DISAPPEARED. In a healthy person, water loss disease is not dangerous because the person THIRSTS and DRINKS; here THIS PROTECTIVE MECHANISM DOES NOT WORK, and the patient DOES NOT DRINK while LOSING FLUIDS because they cannot feel thirsty.

The result is POTENTIALLY FATAL INCREASE IN BLOOD SODIUM. In these patients, FLUID INTAKE should not be guided by THIRST, but should follow a PLANNED SCHEDULE and DAILY WEIGHING.

THERE IS ALSO A LIFE-THREATENING DIFFERENTIAL DIAGNOSIS: a VASCULAR BULGE (aneurysm) in this region may appear as a MASS on imaging; before intervention, it must be EXCLUDED BY VASCULAR IMAGING.

Rapid management

IT IS A SEPARATE GROUP OF DISEASES: it originates in the area ABOVE the pituitary and also affects the HYPOTHALAMUS region just above.
HYPOTHALAMUS governs thirst, satiety, body temperature and SLEEP PATTERNS → in addition to hormone deficiency, UNCONTROLLED WEIGHT GAIN, SLEEP DISTURBANCE, BEHAVIORAL CHANGE and TEMPERATURE IRREGULARITY are seen.
THE MOST DANGEROUS PICTURE — FEELING OF THIRST LOSS OF WATER: the patient has both DEHYDRATION DISEASE AND THE FEELING OF THIRST HAS DISAPPEARED.
Water loss disease is not dangerous in a healthy person because the person THIRSTS and DRINKS; HERE THIS PROTECTIVE MECHANISM DOES NOT WORK → THE PATIENT DOES NOT DRINK BECAUSE HE IS NOT THIRSTY WHILE LOSING FLUIDS → BLOOD SODIUM ELEVATION WHICH CAN BE FATAL.
RULE:
IN THESE PATIENTS, FLUID INTAKE IS CARRIED OUT ACCORDING TO THE PLANNED SCHEDULE AND DAILY SCALE, NOT ACCORDING TO THE FEELING OF THIRST; patients and their relatives are EDUCATED on this issue.
VITAL DIFFERENTIAL DIAGNOSIS:
THE VASCULAR BUBBLE (ANEURYSM) in this area may appear as a mass on imaging → IS EXCLUDED BY VASCULAR IMAGING before the intervention; An attempt without exclusion is FATAL.
OTHER DIFFERENTIAL DIAGNOSES:
Rathke's sac cyst, meningioma, germ cell tumors, pituititis, granulomatous and infiltrative diseases.
AGE DISTRIBUTION IS TWO:
CHILDHOOD AND ADVANCED ADULTHOOD.
The most common first finding in children is GROWTH ARREST and HEADACHE.
VISION is affected frequently and OFFICIAL VISUAL FIELD EXAMINATION is required.
PRIORITY IN HORMONE EVALUATION is CORTISOL and FREE T4 is used for THYROID.
SINCE HYPOPHYSEAL INSUFFICIENCY AFTER TREATMENT IS ALMOST THE RULE, LIFELONG FOLLOW-UP IS REQUIRED.
ALL DOSES AND THRESHOLDS SHOULD BE VALIDATED FROM THE INSTITUTIONAL PROTOCOL.

Drug	Adult	Pediatric	Route	Duration
THE MOST DANGEROUS PICTURE — Thirst Loss of Water with Loss of Water This condition is the most dangerous consequence of hypothalamic involvement, and once its mechanism is understood, it is clearly seen why it is so risky. Water balance in the body is maintained by two separate mechanisms. The first is a hormone that limits water loss through the kidneys; when this hormone decreases, the kidney cannot retain water, and the person excretes a large amount of dilute urine. The second is the sensation of thirst; when the blood becomes concentrated, the center in the brain is stimulated, the person becomes thirsty, and replenishes the lost water by drinking. When only the first mechanism is impaired, the condition is not dangerous because the second mechanism is active; the patient urinates a lot but maintains balance by drinking plenty of water. The danger arises when the thirst center is also damaged due to hypothalamic involvement. In this case, water loss continues, but the sensation of thirst does not occur; the person does not drink because they do not feel thirsty, and blood sodium rises rapidly. This increase can progress to confusion, seizures, and death. Therefore, in these patients, fluid intake cannot be left to the feeling of thirst.	In these patients, THIRST MAY ALSO BE LOST along with WATER LOSS DISEASE. In this case, FLUID INTAKE CANNOT BE LEFT TO THE FEELING OF THIRST; It should be carried out according to a PLANNED SCHEDULE and DAILY SCALE. Patients and their relatives SHOULD BE EDUCATED ABOUT DAILY SCALE, URINE AMOUNT and SYMPTOMS. Fluid plan and follow-up criteria SHOULD BE VERIFIED FROM THE INSTITUTIONAL PROTOCOL	This picture is more dangerous in children; The family should be educated in detail and the school and caregivers should be informed	—	For life
CRITICAL DIFFERENTIAL DIAGNOSIS — no intervention should be performed without ruling out an aneurysm When planning an intervention for a mass located in the sellar and parasellar region, there is a possibility that must be excluded, which, if overlooked, can have fatal consequences. This region is immediately adjacent to the area where the brain's largest blood vessels course and branch. A ballooning in one of these vessels, that is, an aneurysm, can cause pressure on surrounding structures as it grows, producing symptoms similar to a tumor; loss of visual field, restriction of eye movements, and headaches can occur. It can also produce an appearance resembling a mass on cross-sectional imaging. If this possibility is not considered, the patient is taken for intervention with the diagnosis of a mass; piercing the aneurysm wall with a needle or surgical instrument can lead to uncontrolled bleeding, which can be fatal. The way to prevent this situation is simple: in patients planned for intervention, imaging showing the vascular structures should be performed, and this possibility should be ruled out. This step should not be neglected, especially when unusual features are found in imaging and in patients with affected eye movements.	A VASCULAR BALLOON (aneurysm) in this region can appear LIKE A MASS on imaging. In patients planned for intervention, this possibility must be RULED OUT with VASCULAR IMAGING; biopsy or surgery performed without ruling it out can lead to FATAL BLEEDING. The choice of imaging method should be VERIFIED FROM THE INSTITUTIONAL PROTOCOL	The same rule applies in children, and the evaluation is done in an experienced center	Imaging	Before intervention
Recognition of the findings of hypothalamic involvement The hypothalamus, located just above the pituitary gland, is a control center that manages the body's fundamental balances, and masses affecting this area cause consequences beyond hormone deficiency. This region regulates the feeling of fullness; when it is affected, no matter how much a person eats, they do not feel satisfied, and weight gain becomes uncontrollable. This weight gain is not a simple nutritional problem; the expected response cannot be achieved with diet and exercise, which creates difficulties for both the patient and the physician. The same area controls sleep and wakefulness; patients exhibit excessive daytime sleepiness, nighttime insomnia, and irregular sleep patterns. Behavioral and personality changes may occur; relatives may notice that the person is not the same as before, and these changes are often attributed to psychological reasons. The regulation of body temperature can be disrupted. The most dangerous issue is the disruption of the thirst sensation. The common feature of these findings is that they do not appear unless directly asked about and are attributed to other causes.	HYPOTHALAMIC INVOLVEMENT presents with the following findings: UNCONTROLLED WEIGHT GAIN and LOSS OF SATIETY, DISRUPTION OF SLEEP PATTERNS and DAYTIME SLEEPINESS, BEHAVIORAL and PERSONALITY CHANGES, DISORDER OF BODY TEMPERATURE and IMPAIRED THIRST. These findings SHOULD ALSO BE INQUIRED ABOUT because they may be attributed to hormonal deficiency or psychological causes	In children, a decline in school performance, behavioral changes, and rapid weight gain should also be evaluated.	—	At diagnosis and follow-up
Age distribution and initial findings in children The bimodal age distribution of craniopharyngioma also determines how the diagnosis comes to mind, because the presentation differs between the two age groups. In childhood, the most common and earliest sign is growth stagnation; since the effect of growth hormone is usually affected first, the child's height growth slows down or stops. Since this change is slow, the family may not notice it; however, it is clearly seen in a regularly monitored growth chart. Therefore, a central cause should be investigated in a child whose height growth is below expected. The second most common symptom in children is headache, and if this headache is noticeable in the morning and accompanied by vomiting, it suggests increased intracranial pressure. In adults, the picture is different; since there is no longer growth, the first symptoms are generally complaints related to visual field loss and hormone deficiencies. In adults, weight gain and behavioral changes due to hypothalamic involvement are often attributed to psychological reasons, leading to delayed diagnosis.	The age distribution of craniopharyngioma is BIPHASIC: CHILDHOOD and LATE ADULTHOOD. The most common initial findings in children are GROWTH ARREST and HEADACHE; therefore, in children with slowed height growth, the GROWTH CURVE should be examined and a central cause investigated. In adults, VISION IMPAIRMENT and HORMONE DEFICIENCIES come to the fore.	In children, the growth curve must be examined; the combination of halted height growth and headache is alerting	—	At the first assessment
Vision and hormone evaluation In these masses, vision and hormone evaluation are based on the same principles as in pituitary adenomas but extend with a few additional points. Visual field testing should be done with an official method because the loss develops slowly and the patient may not notice it; a crude examination may not show this loss. Since the visual pathways in these masses can be affected from different angles, the pattern of loss is also variable. In hormone evaluation, cortisol is prioritized; if deficiency is overlooked, the patient can develop adrenal crisis during surgery or an intercurrent illness. In thyroid evaluation, TSH is not reliable because the disorder is at the level of the pituitary and above; free T4 should be used. Additionally, in these masses, assessment of water balance is mandatory because due to stalk and hypothalamic involvement, diabetes insipidus is common, and this condition may be masked by cortisol deficiency; it should be kept in mind that it may appear after starting cortisone. In children, growth hormone and pubertal status should also be assessed.	OFFICIAL VISUAL FIELD EXAMINATION should be performed; gross examination may not show loss. PRIORITY IN HORMONE EVALUATION IS CORTISOL; thyroid assessment is done with FREE T4, not TSH. WATER BALANCE should also be evaluated. The scope of the tests should be CONFIRMED FROM THE INSTITUTIONAL PROTOCOL.	In children, growth hormone and puberty status are evaluated separately	Laboratory and eye examination	At the time of diagnosis
Permanent insufficiency and lifelong follow-up after treatment In the treatment of craniopharyngiomas and similar parasellar masses, the control of the disease itself is the beginning, not the end, of the process; these patients live with a lifelong need for monitoring and treatment. Since the location of the mass is very close to the pituitary stalk and hypothalamus, surgical intervention may not be completed without affecting these structures; radiotherapy also affects the same area. As a result, most patients develop deficiencies in multiple pituitary hormones, and replacement of these deficiencies continues lifelong. Deficiency of the water balance hormone is particularly common in these patients and management is challenging if the sense of thirst is also impaired. There is also a delayed problem in patients who have received radiotherapy: new hormone deficiencies can appear years after treatment, so a single normal assessment is not sufficient. Weight gain and sleep problems due to hypothalamic involvement continue after treatment and are among the issues that most affect the patient’s quality of life.	Pituitary insufficiency is almost the rule after surgery and RADIATION THERAPY; in most patients, REPLACEMENT OF MORE THAN ONE HORMONE FOR LIFE is necessary. In addition, new deficiencies may appear YEARS AFTER RADIATION THERAPY. FOLLOW-UP should be maintained lifelong, and PATIENT EDUCATION should be provided (according to the relevant protocol).	Growth, puberty, and school performance should be monitored in children, and a transfer plan should be made when transitioning to adulthood.	—	For life
Other parasellar masses in differential diagnosis Not all masses located in the sellar and parasellar region are pituitary adenomas or craniopharyngiomas; there are other diseases in this region with completely different treatments, and distinguishing them directly determines the treatment. Rathke's cleft cyst is a commonly seen structure and usually does not cause problems. Meningioma originates from surrounding tissue and can be distinguished by imaging features. Germ cell tumors are particularly seen in children and young adults, and distinguishing these tumors is critical because their treatment relies more on medication and radiation therapy rather than surgery. Hypophysitis is the inflammation of the gland and may be associated with drugs such as immune checkpoint inhibitors. Granulomatous and infiltrative diseases can affect by thickening the pituitary stalk. Among these differential diagnoses, there is a particularly notable pattern: seeing thickening of the pituitary stalk along with rapidly developing diabetes insipidus in a young patient should primarily suggest germ cell tumors and infiltrative diseases.	Other masses are also present in the parasellar region, and their treatments are different: RATHKE'S CLEFT CYST, MENINGIOMA, GERMLINE CELL TUMORS, HYPOPHYSITIS, GRANULOMATOUS and INFILTRATIVE diseases. Rapidly developing water loss disease and stalk thickening in a YOUNG patient should suggest GERMLINE CELL TUMOR and INFILTRATIVE diseases. The scope of evaluation should be confirmed by INSTITUTIONAL PROTOCOL	In children, germ cell tumors and infiltrative diseases should be primarily considered	—	During the diagnostic process

Alternative

Non-functioning pituitary adenoma originates from the pituitary itself, and hypothalamic involvement is not expected (relevant protocol).
An aneurysm can appear like a mass and should be excluded with vascular imaging before any intervention.
Rathke's cleft cyst is generally a benign structure that usually does not cause problems.
Germ cell tumors should be considered in young patients with rapidly developing diabetes insipidus and stalk thickening.
Meningioma originates from surrounding tissue and is distinguished by imaging features.
Hypophysitis is distinguished by drug history and clinical course (relevant protocol).
Granulomatous and infiltrative diseases can cause stalk thickening.
Diabetes insipidus due to other causes is much less dangerous when the sense of thirst is preserved (relevant protocol).

Red flags

In a patient with LOSS OF THIRST, leaving fluid intake to THIRST → the patient does not drink because they are not thirsty while losing fluid, leading to potentially fatal HYPERNATREMIA.
In these patients, not implementing DAILY WEIGHTS and a PLANNED FLUID CHART → this is the only safe monitoring method.
Not educating the patient and relatives about LOSS OF THIRST → the patient may be losing fluid even while feeling well.
Performing a BIOPSY or SURGERY on the mass in this area without ruling out ANEURYSM → opening of the vessel wall leads to UNCONTROLLABLE and FATAL BLEEDING.
Skipping vascular imaging in a patient with UNUSUAL FEATURES on imaging or IMPAIRED EYE MOVEMENTS → the aneurysm can mimic these presentations.
Failing to investigate findings of HYPOTHALAMIC INVOLVEMENT → UNCONTROLLED WEIGHT GAIN, SLEEP DISORDER, BEHAVIORAL CHANGES, and TEMPERATURE DYSREGULATION will not appear unless directly questioned.
Considering uncontrollable weight gain as AN ORDINARY NUTRITIONAL PROBLEM → the expected response to diet and exercise CANNOT BE ACHIEVED; this is a LOSS OF SATIETY.
Attributing behavioral and personality changes to PSYCHOLOGICAL CAUSES → could be a sign of hypothalamic involvement.
Not examining the GROWTH CURVE in a CHILD → the most frequent and earliest finding is GROWTH STAGNATION, which the family may not notice.
Evaluating the VISUAL FIELD only by gross examination → loss develops slowly and the patient DOES NOT NOTICE.
Performing an intervention without knowing the CORTISOL status → ADRENAL CRISIS occurs during surgical stress.
Performing thyroid evaluation with TSH alone → TSH is NOT RELIABLE for this level of disorder.
Not knowing that DIABETES INSIPIDUS can appear after starting cortisone → cortisol deficiency HIDES this presentation (relevant protocol).
Keeping post-treatment follow-up short → PITUITARY FAILURE is ALMOST RULE and new deficiencies may appear YEARS AFTER RADIATION THERAPY.
Failing to investigate rapid water loss and THICKENING OF THE STALK in a YOUNG patient → GERM CELL TUMORS and INFILTRATIVE diseases should be considered.

Disposition and follow-up

Green zone: Patient with confirmed diagnosis, regulated treatment, stable fluid balance, and preserved sense of thirst: outpatient follow-up, planned hormone evaluation, and visual field examination.
Yellow zone: New diagnosis, visual field loss, findings of hypothalamic involvement, hormone deficiency, planned surgery or intervention, growth stagnation in a child: accelerated evaluation and referral to an experienced center; aneurysm is ruled out before intervention and cortisol status is clarified.
Red zone: Thirst in a patient with losses accompanied by confusion, excessive urination, weight loss, or severe sodium elevation: urgent evaluation (relevant protocol). Sudden severe headache, rapid deterioration of vision, or change in consciousness: urgent evaluation. Hypotension and vomiting: adrenal crisis should be considered and treatment should not be delayed (relevant protocol).

Key clinical points

READ FIRST — the most dangerous scenario: patient who does not feel thirsty

THE MOST DANGEROUS CONSEQUENCE OF HYPOTHALAMIC INVOLVEMENT | MECHANISM — BODY WATER BALANCE IS MAINTAINED BY TWO SEPARATE MECHANISMS: (1) HORMONE THAT LIMITS WATER LOSS FROM THE KIDNEYS — when deficient, the kidney cannot RETAIN WATER and the person excretes LARGE AMOUNTS OF DILUTED URINE | (2) THIRST FEELING — when blood is concentrated, the CENTER IN THE BRAIN IS STIMULATED, the person FEELS THIRSTY and REPLACES THE LOST WATER BY DRINKING | ONLY WHEN THE FIRST MECHANISM IS IMPAIRED, THE CONDITION IS NOT DANGEROUS because THE SECOND MECHANISM TAKES OVER: the patient EXCRETES A LOT OF URINE but MAINTAINS BALANCE BY DRINKING LOTS OF WATER | DANGER ARISES WHEN THE THIRST CENTER IS ALSO DAMAGED DUE TO HYPOTHALAMIC INVOLVEMENT: water loss continues but NO THIRST OCCURS → the person DOES NOT DRINK BECAUSE THEY DO NOT FEEL THIRSTY → BLOOD SODIUM RISES RAPIDLY → CONFUSION, SEIZURES, AND DEATH | RULE: in these patients, FLUID INTAKE CANNOT BE LEFT TO THIRST → it should be carried out according to a PLANNED SCHEDULE and DAILY WEIGHT MONITORING | The patient and relatives are EDUCATED about DAILY WEIGHT, URINE OUTPUT, and SYMPTOMS | Fluid plan should be VERIFIED FROM INSTITUTIONAL PROTOCOL

This condition is the most dangerous consequence of hypothalamic involvement. Water balance is maintained by two mechanisms: a hormone that limits water loss from the kidney and the feeling of thirst. When only the hormone is deficient, the condition is not dangerous because the person feels thirsty and maintains balance by drinking. Danger arises when the thirst center is damaged due to hypothalamic involvement; water loss continues but no thirst occurs, the person does not drink, and blood sodium rises rapidly, leading to confusion, seizures, and death. Therefore, fluid intake cannot be left to the feeling of thirst; it should be carried out according to a planned schedule and daily weight monitoring. The patient and relatives should be educated about daily weight, urine output, and symptoms.

LIFE-THREATENING — aneurysm mimics a mass

POSSIBILITY THAT MUST BE EXCLUDED WHEN PLANNING AN INTERVENTION AND CAN HAVE FATAL CONSEQUENCES IF OVERLOOKED | ANATOMICAL RATIONALE: this area is immediately adjacent to the region where THE LARGEST BLOOD VESSELS OF THE BRAIN RUN AND BRANCH | When a BUBBLE (aneurysm) forms in one of these vessels and grows, it exerts pressure on the surrounding structures and gives symptoms JUST LIKE A TUMOR: LOSS OF VISUAL FIELD | RESTRICTED EYE MOVEMENTS | HEADACHE | In cross-sectional imaging, it can also create an appearance RESEMBLING A MASS | WHEN THIS POSSIBILITY IS NOT CONSIDERED: the patient is taken for intervention with a MASS DIAGNOSIS → the needle or surgical instrument may OPEN THE ANEURYSM WALL, LEADING TO UNCONTROLLABLE BLEEDING that can be FATAL | THE WAY TO PREVENT IT IS SIMPLE: imaging that shows the VASCULAR STRUCTURES should be performed in patients planned for intervention, and this possibility should be EXCLUDED | SITUATIONS THAT MUST NOT BE NEGLECTED: UNUSUAL FEATURES in imaging | patients with AFFECTED EYE MOVEMENTS

When planning an intervention in this area, there is a possibility that must be excluded and can have fatal consequences if overlooked. This area is immediately adjacent to the region where the largest blood vessels of the brain run; when an aneurysm forms in one of these vessels and grows, it can press on surrounding structures, just like a tumor, causing visual field loss, restricted eye movements, and headache, and may resemble a mass in imaging. If this possibility is not considered, the patient is taken for intervention with a mass diagnosis, and opening the aneurysm wall can lead to uncontrollable bleeding, which can be fatal. The preventive measure is simple: vascular imaging should be performed in patients planned for intervention. This step should not be neglected, especially in cases with unusual imaging features and patients with affected eye movements.

Hypothalamic involvement — does not appear unless specifically questioned

THE HYPOTHALAMUS IMMEDIATELY ABOVE THE PITUITARY is a CONTROL CENTER THAT MANAGES THE BODY'S BASIC BALANCES → masses affecting this area cause consequences BEYOND HORMONE DEFICIENCY | (1) SATIETY FEELING: when impaired, the person DOES NOT FEEL FULL NO MATTER HOW MUCH THEY EAT → WEIGHT GAIN BECOMES UNCONTROLLABLE | WARNING: this is NOT AN ORDINARY NUTRITIONAL PROBLEM — the expected response CANNOT BE ACHIEVED WITH DIET and EXERCISE, creating DIFFICULTIES for BOTH THE PATIENT AND THE PHYSICIAN | (2) SLEEP and WAKEFULNESS PATTERNS: EXCESSIVE DAYTIME SLEEPINESS, NIGHTTIME INSOMNIA, IRREGULAR SLEEP PATTERNS | (3) BEHAVIORAL and PERSONALITY CHANGES: relatives of the patient NOTICE THAT THE PERSON IS NOT THE SAME → these changes are FREQUENTLY ATTRIBUTED TO PSYCHOLOGICAL REASONS | (4) REGULATION OF BODY TEMPERATURE can be disrupted | (5) MOST DANGEROUS: IMPAIRMENT OF THIRST SENSATION | COMMON CHARACTERISTIC OF THESE FINDINGS: THEY DO NOT APPEAR UNLESS DIRECTLY ASKED and ARE ATTRIBUTED TO OTHER REASONS → SHOULD BE INQUIRED AS WELL

The hypothalamus immediately above the pituitary is a control center managing the body's basic balances, and masses affecting this area cause consequences beyond hormone deficiency. When satiety is impaired, the person does not feel full no matter how much they eat, and weight gain becomes uncontrollable; this is not an ordinary nutritional problem because the expected response cannot be achieved with diet and exercise. Sleep and wakefulness patterns are disrupted; excessive daytime sleepiness and nighttime insomnia are observed. Behavioral and personality changes may occur, and these are frequently attributed to psychological reasons. The regulation of body temperature can be disrupted. The most dangerous is the impairment of thirst sensation. The common feature of these findings is that they do not appear unless directly asked.

Bimodal age distribution and mode of presentation

THE AGE DISTRIBUTION IS BIMOdal, and THIS DETERMINES HOW THE DIAGNOSIS COMES TO MIND because the way of presenting is different in the two age groups | CHILDHOOD — THE MOST COMMON AND EARLIEST SIGN IS A PAUSE IN GROWTH: since the effect on the growth hormone GENERALLY OCCURS FIRST, the child's HEIGHT GROWTH SLOWS OR STOPS | Because this change is SLOW, the FAMILY MAY NOT NOTICE — however, it is CLEARLY SEEN on a REGULARLY MONITORED GROWTH CURVE → in a child whose height gain is BELOW EXPECTED, A CENTRAL CAUSE IS INVESTIGATED | The second most common sign in children is HEADACHE; when it is PROMINENT IN THE MORNING and accompanied by VOMITING, it suggests INCREASED INTRACRANIAL PRESSURE | THE PRESENTATION IN ADULTS IS DIFFERENT: since growth is no longer a factor, the first signs are usually LOSS OF VISUAL FIELD and complaints due to HORMONE DEFICIENCIES | In adults, WEIGHT GAIN and BEHAVIORAL CHANGES due to HYPOTHALAMIC INVOLVEMENT are often ATTRIBUTED TO PSYCHOLOGICAL REASONS, which DELAYS THE DIAGNOSIS

The bimodal age distribution determines how the diagnosis comes to mind because the way of presenting is different in the two age groups. In childhood, the most common and earliest sign is a pause in growth; since the growth hormone is generally affected first, height growth slows or stops. Because this change is slow, the family may not notice, but it is clearly seen on a regularly monitored growth curve. The second most common sign in children is headache; when it is prominent in the morning and accompanied by vomiting, it suggests increased intracranial pressure. In adults, the first signs are usually loss of visual field and hormone deficiencies; weight gain and behavioral changes due to hypothalamic involvement are often attributed to psychological reasons, delaying the diagnosis.

Evaluation, differential diagnosis, and lifelong follow-up

VISION: OFFICIAL VISUAL FIELD EXAMINATION should be performed — loss develops SLOWLY, the patient DOES NOT NOTICE, and ROUGH EXAMINATION MAY NOT SHOW IT; in these masses, visual pathways can be affected at DIFFERENT ANGLES, so the PATTERN OF LOSS IS ALSO VARIABLE | HORMONES: PRIORITY IS CORTISOL (if overlooked, DURING SURGERY or INTERCURRENT ILLNESS, ADRENAL CRISIS may occur) | FOR THYROID, USE FREE T4, NOT TSH | WATER BALANCE should be evaluated separately — due to involvement of the stalk and hypothalamus, DIABETES INSIPIDUS is COMMON, and this picture CAN BE MASKED BY CORTISOL DEFICIENCY; it should be remembered that it CAN EMERGE AFTER STARTING CORTISONE | DIFFERENTIAL DIAGNOSIS — not every mass in this region is an adenoma or craniopharyngioma: RATHKE’S CLEFT CYST (usually asymptomatic) | MENINGIOMA | GERM CELL TUMORS (especially in children and young adults — DISTINGUISHING IS CRITICAL because their treatment relies more on DRUGS and RADIATION than SURGERY) | HYPOPHYSITIS | GRANULOMATOUS and INFILTRATIVE diseases (affecting the stalk BY THICKENING IT) | NOTEWORTHY PATTERN: in a YOUNG patient, RAPIDLY DEVELOPING DIABETES INSIPIDUS + THICKENING OF THE PITUITARY STALK → primarily suggests GERM CELL TUMOR and INFILTRATIVE diseases | FOLLOW-UP: post-treatment, HYPOPHYSEAL INSUFFICIENCY is ALMOST RULE and new deficiencies can appear YEARS AFTER RADIATION THERAPY → LIFE-LONG follow-up | Hypothalamic-origin WEIGHT GAIN and SLEEP PROBLEMS PERSIST EVEN AFTER TREATMENT

Visual field examination should be performed by official methods because loss develops slowly and may not be detected in a crude exam. In hormone evaluation, priority is given to cortisol, and free T4 is used for thyroid assessment. Water balance should also be evaluated because diabetes insipidus is common and can be masked by cortisol deficiency; it should be kept in mind that it may appear after starting cortisone. Differential diagnosis includes Rathke’s cleft cyst, meningioma, germ cell tumors, hypophysitis, as well as granulomatous and infiltrative diseases; distinguishing germ cell tumors is critical because their treatment depends more on drugs and radiation than on surgery. In young patients, rapidly developing diabetes insipidus with stalk thickening suggests these diagnoses. Post-treatment hypophyseal insufficiency is almost universal, and follow-up is lifelong.

Featured external sources

French craniopharyngioma consensus 2024.Current diagnosis and long-term follow-up in children and adults.
Craniopharyngioma consensus guideline 2024Multidisciplinary surgery, radiotherapy, and endocrine follow-up.
Endocrine Society hypopituitarism guideline.Pituitary axes and hormone replacement.

Detailed assessment

Diagnostic and decision reasoning

Clinical framework

Overview

Craniopharyngiomas and other parasellar masses form a separate disease group from the tumors of the pituitary gland itself because they originate from the region above the pituitary; they affect not only hormone production but also the hypothalamus region just above it. Since this region regulates thirst, satiety, body temperature, and sleep patterns, these patients experience uncontrolled weight gain, sleep disturbances, behavioral changes, and temperature dysregulation.

The most dangerous scenario is the loss of thirst sensation; the patient has both diabetes insipidus and a loss of the feeling of thirst, so the patient does not drink while losing fluids, leading to potentially fatal increases in blood sodium levels. In these patients, fluid intake should be managed according to a planned schedule and daily weight, not based on thirst.

There is also a critical differential diagnosis: a vascular balloon in this area may appear like a mass in imaging and should be ruled out with vascular imaging before any intervention. The age distribution is bimodal; in children, the most common first sign is growth arrest.

Pituitary insufficiency is almost universal after treatment, and follow-up is lifelong.

Differential diagnosis and assessment

Key considerations

Non-functioning pituitary adenoma originates from the pituitary itself, and hypothalamic involvement is not expected (relevant protocol).
An aneurysm mimics a mass and should be excluded with vascular imaging before intervention.
Rathke's cleft cyst is generally a benign structure that usually does not cause problems.
Germ cell tumors should be considered in young patients with rapidly developing fluid loss and thickening of the pituitary stalk, and their treatment is different.
Meningioma originates from surrounding tissue and is distinguished by imaging features.
Hypophysitis is distinguished by drug history and clinical course (relevant protocol).
Granulomatous and infiltrative diseases involve the pituitary stalk by thickening it.
Diabetes insipidus with preserved thirst is much less dangerous (relevant protocol).

Clinical decision reasoning

Why it matters

The points that determine the clinical outcome in the management of craniopharyngiomas and parasellar masses arise from the extension of the mass beyond the pituitary. The first and most dangerous point is the loss of thirst; since water balance is maintained by two mechanisms, hormone deficiency alone is not dangerous, but when the thirst center is also damaged, the protective mechanism completely disappears, and the patient does not drink because they are not thirsty.

Therefore, fluid management cannot be left to the sensation of thirst and must be conducted according to a planned schedule. The second and potentially fatal point is aneurysm; due to the adjacency of this region to large vessels, an aneurysm can mimic a mass, and an intervention carried out without exclusion can lead to uncontrollable bleeding.

The third point is that signs of hypothalamic involvement do not appear unless directly asked; uncontrolled weight gain is interpreted as a feeding problem, and behavioral change is assumed to have a psychological cause. The fourth point is the age distribution; in children, the growth curve is the earliest clue, and diagnosis is delayed if not monitored regularly.

The last point is the post-treatment period; since pituitary failure is almost inevitable and deficits after radiotherapy may appear years later, follow-up must continue for a lifetime.

Safety and monitoring

Complications and safety

Critical complications

In water loss with loss of thirst, a potentially fatal increase in serum sodium develops.
Taking an aneurysm into intervention without exclusion can lead to uncontrollable and fatal bleeding.
Hypothalamic-origin weight gain is resistant to treatment and persists after treatment.
Sleep disorders and daytime sleepiness significantly impair quality of life.
Visual field loss can be permanent if detected late.
Overlooking cortisol deficiency can lead to adrenal crisis during intervention.
Multiple hormone deficiencies after treatment are almost inevitable and require lifelong treatment.
New deficiencies can appear years after radiotherapy.

Special patient populations

Special considerations

In children, the earliest finding is growth retardation, and the growth curve must be examined.
In patients with loss of thirst, a fluid plan and daily weighing are mandatory.
In every patient planned for intervention, an aneurysm must be excluded and cortisol status clarified.
Lifelong follow-up must be continued in patients who have received radiotherapy.
In young patients, rapidly developing water loss and stalk thickening should raise the consideration of germ cell tumors.
In patients with hypothalamus-origin obesity, nutritional support should also be planned.
In children, a transition plan for follow-up into adulthood should be established.
Education of relatives is critical in patients at risk of altered consciousness.

Follow-up and reassessment

Follow-up plan

Follow-up in craniopharyngioma and parasellar masses continues lifelong and covers multiple headings simultaneously. Daily weighing is at the center of water balance monitoring; fluid intake should be managed according to a planned schedule in patients with loss of thirst, and this plan should be adjusted according to weight changes.

The patient and relatives should be re-educated on this in every visit, and signs such as increased urine volume, weight loss, fatigue, and confusion should be reviewed; in these patients, feeling well does not mean it is safe. Hormone assessment should be repeated at intervals specified in the institutional protocol, and patients who still require cortisol should receive instruction on sick day rules, needle application during vomiting, and warning card education, which should be regularly refreshed.

In patients who have received radiation therapy, new hormone deficiencies may appear years later, so screening should be maintained, and responsibility for follow-up should be clearly defined. Visual field examination should be repeated as scheduled.

Hypothalamus-origin weight gain should be addressed separately; the patient should be informed that this is not an ordinary nutrition problem, and nutritional support should be provided; if this explanation is not given, the patient may blame themselves and disengage from follow-up. Sleep problems and behavioral changes should be queried and, if necessary, managed together with related specialties.

In children, growth, puberty, and school performance should be monitored, and transition planning into adulthood should be implemented.